Hormonal
Treatment with tirzepatide is associated with numerically lower impairment in health-related quality of life (HRQoL) domains and work productivity compared to non-pharmacological management or other obesity medications in real-world settings.
If you are managing obesity with tirzepatide, you may experience better daily functioning and work productivity compared to managing it without medication, although individual results vary. This medication is typically taken once weekly alongside diet and exercise. Real-world data suggests these benefits are most pronounced when combined with weight loss.
PwO in the tirzepatide group reported higher scores for most of the Short Form Health Survey version 2 (SF-36v2) domains than other groups... A general trend towards greater work impairment among PwO in the non-OMM group than PwO in the tirzepatide and OMM groups was observed.
Why this rating
The study is a cross-sectional, real-world observational analysis with no formal statistical adjustments or randomization, limiting causal inference.
Source
Health-Related Quality of Life and Work-Related Outcomes in People with Obesity or Overweight Treated with Tirzepatide or Other Obesity Medications: United States Results from the Adelphi Real World Obesity Disease Specific Programme™
Theresa Hunter et al. · Advances in Therapy · 2026
DOI 10.1007/s12325-026-03580-w
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →